Why Compare Nanosecond and Picosecond Lasers for Melasma?
The choice matters. Melasma can appear as soft brown patches across the cheeks, forehead, or upper lip, yet its causes and responses to treatment vary. A laser’s pulse duration is only one part of the decision. Wavelength, energy, skin type, recent sun exposure, and prior treatments also matter. Dr. Pearl E. Grimes, a dermatologist known for her work on pigmentary disorders, has described melasma as “one of the most challenging disorders to treat.” That difficulty is worth remembering before comparing devices.
This introduction to Melasma Nanosecond Picosecond Laser treatment examines how the two technologies differ without assuming that newer always means better. Nanosecond lasers deliver energy in billionths of a second; picosecond lasers use trillionths. Their effects depend on the device settings and the person’s skin, so published comparisons should be read carefully. Laser treatment may help selected patients, but irritation or post-inflammatory darkening can occur, and pigmentation may return. It is not a guaranteed fix.
A thoughtful comparison asks what evidence supports each approach, which patients were studied, and how outcomes were measured. It also considers the clinician’s experience and the role of sun protection and ongoing care. One limitation deserves attention: studies do not always compare identical settings or patient groups. That makes simple rankings unreliable. For readers weighing options, the practical question is not merely which pulse is shorter, but which plan fits their skin and risk profile.
What Melasma Is and Why Laser Treatment Requires Careful Selection
Melasma is a chronic pigment disorder that often creates symmetrical brown or gray patches on the cheeks, forehead, and upper lip. It is more than a surface stain: pigment may sit at different skin depths, and sunlight can keep activating it. A clinical and epidemiological review in Anais Brasileiros de Dermatologia reported prevalence estimates of about 1% in the general population and up to 50% in some higher-risk groups; estimates vary with population and study methods (Handel et al., 2014).
Careful assessment matters. Skin tone, patch depth, prior treatments, and triggers such as ultraviolet and visible light can all affect treatment choices. A laser may lighten pigment, but it can also cause irritation or post-inflammatory darkening, especially in more pigment-prone skin. Not a simple trade-off. A review in Dermatology and Therapy describes recurrence and treatment-related pigment changes as continuing challenges in melasma care (Ogbechie-Godec and Elbuluk, 2017).
Nanosecond and picosecond lasers deliver energy over different pulse durations, but a shorter pulse does not automatically mean safer or better results. Clinicians weigh settings, test areas, skin response, and whether laser treatment is appropriate at all. Daily broad-spectrum sun protection remains essential; visible-light protection may also be discussed. The choice can be less obvious than a device comparison suggests. Individual responses vary.
